Biologic Therapy in Pediatric JIA Uveitis

计划入组 250 人 · 首次发布于 2022 年 9 月 15 日

PANLAR's Latin American Registry of Rheumatic Patients Treated With Jak Inhibitors

计划入组 3,000 人 · 首次发布于 2021 年 3 月 29 日

Retrospective Analysis of Pulmonary Arterial Hypertension (PAH) and Related Complications in Juvenile Idiopathic Arthritis (JIA) Participants Treated With Biologic and Non-biologic Disease-modifying Anti-rheumatic Drugs (DMARDs)

计划入组 4,557 人 · 首次发布于 2016 年 5 月 27 日

DMARDs

biologic therapeutic

biologic cocktail

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Molecular Templates

United States

MediWound

Israel

SynAct Pharma Completes Enrollment in Phase 2b Trial of Resomelagon for Newly Diagnosed Rheumatoid Arthritis

Large Real-World Study Finds No Increased Cancer or Cardiovascular Risk with JAK Inhibitors in Rheumatoid Arthritis

FDA Approves First Neuroimmune Modulation Device for Rheumatoid Arthritis Treatment